» Articles » PMID: 27597962

Transneuronal Degeneration of Thalamic Nuclei Following Middle Cerebral Artery Occlusion in Rats

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2016 Sep 7
PMID 27597962
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective. Postinfarction transneuronal degeneration refers to secondary neuronal death that occurs within a few days to weeks following the disruption of input or output to synapsed neurons sustaining ischemic insults. The thalamus receives its blood supply from the posterior circulation; however, infarctions of the middle cerebral arterial may cause secondary transneuronal degeneration in the thalamus. In this study, we presented the areas of ischemia and associated transneuronal degeneration following MCAo in a rat model. Materials and Methods. Eighteen 12-week-old male Sprague-Dawley rats were randomly assigned to receive middle cerebral artery occlusion surgery for 1, 7, and 14 days. Cerebral atrophy was assessed by 2,3,5-triphenyltetrazolium hydrochloride staining. Postural reflex and open field tests were performed prior to animal sacrifice to assess the effects of occlusion on behavior. Results. Myelin loss was observed at the lesion site following ischemia. Gliosis was also observed in thalamic regions 14 days following occlusion. Differential degrees of increased vascular endothelial growth factor expression were observed at each stage of infarction. Increases in myelin basic protein levels were also observed in the 14-day group. Conclusion. The present rat model of ischemia provides evidence of transneuronal degeneration within the first 14 days of occlusion. The observed changes in protein expression may be associated with self-repair mechanisms in the damaged brain.

Citing Articles

Ischemic Conditioning Promotes Transneuronal Survival and Stroke Recovery via CD36-Mediated Efferocytosis.

Ju H, Kim I, Pavlova I, Mu S, Park K, Minkler J Circ Res. 2025; 136(5):e34-e51.

PMID: 39886760 PMC: 11867857. DOI: 10.1161/CIRCRESAHA.124.325428.


Secondary thalamic dysfunction underlies abnormal large-scale neural dynamics in chronic stroke.

Johnston P, Griffiths J, Rokos L, McIntosh A, Meltzer J Proc Natl Acad Sci U S A. 2024; 121(46):e2409345121.

PMID: 39503890 PMC: 11573628. DOI: 10.1073/pnas.2409345121.


Vascular tortuosity is related to reduced thalamic volume after middle cerebral artery occlusion.

Wei W, Lao H, Tan Y, Liang S, Ye Z, Qin C Heliyon. 2023; 9(5):e15581.

PMID: 37159683 PMC: 10163615. DOI: 10.1016/j.heliyon.2023.e15581.


Transneuronal Degeneration in the Visual Pathway of Rats following Acute Retinal Ischemia/Reperfusion.

Fu Y, Hu T, Zhang Q, Meng S, Lu Y, Xiang A Dis Markers. 2021; 2021:2629150.

PMID: 34917198 PMC: 8670974. DOI: 10.1155/2021/2629150.


Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves Recovery.

Nguyen T, Crumpacker R, Calderon K, Garcia F, Zbesko J, Frye J J Pharmacol Exp Ther. 2021; 380(2):126-141.

PMID: 34893553 PMC: 11048261. DOI: 10.1124/jpet.121.000711.


References
1.
Hata R, Mies G, Wiessner C, Fritze K, Hesselbarth D, Brinker G . A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J Cereb Blood Flow Metab. 1998; 18(4):367-75. DOI: 10.1097/00004647-199804000-00004. View

2.
Hardy J . Pathways to primary neurodegenerative disease. Ann N Y Acad Sci. 2001; 924:29-34. DOI: 10.1111/j.1749-6632.2000.tb05556.x. View

3.
Dirnagl U, Iadecola C, Moskowitz M . Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999; 22(9):391-7. DOI: 10.1016/s0166-2236(99)01401-0. View

4.
Zhang J, Zhang Y, Xing S, Liang Z, Zeng J . Secondary neurodegeneration in remote regions after focal cerebral infarction: a new target for stroke management?. Stroke. 2012; 43(6):1700-5. DOI: 10.1161/STROKEAHA.111.632448. View

5.
Bederson J, Pitts L, Germano S, Nishimura M, Davis R, Bartkowski H . Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986; 17(6):1304-8. DOI: 10.1161/01.str.17.6.1304. View